PolyPid (PYPD) Earnings Date & Reports

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYPD is expected to report earnings to fall 18.58% to -92 cents per share on May 07

Q1'25

Est.

$-0.92

Q4'24

Missed

by $0.22

Q3'24

Missed

by $0.22

Q2'24

Beat

by $0.05

Q1'24

Beat

by $2.78

The last earnings report on February 12 showed earnings per share of -112 cents, missing the estimate of -91 cents. With 13.61K shares outstanding, the current market capitalization sits at 27.62M.

View a ticker or compare two or three

Compare

PYPD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PYPD
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com